"DNA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Descriptor ID |
D004247
|
MeSH Number(s) |
D13.444.308
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA".
Below are MeSH descriptors whose meaning is more specific than "DNA".
- DNA
- DNA Adducts
- DNA Transposable Elements
- DNA, A-Form
- DNA, Algal
- DNA, Ancient
- DNA, Antisense
- DNA, Archaeal
- DNA, B-Form
- DNA, Bacterial
- DNA, C-Form
- DNA, Catalytic
- DNA, Circular
- DNA, Concatenated
- DNA, Cruciform
- DNA, Fungal
- DNA, Helminth
- DNA, Intergenic
- DNA, Neoplasm
- DNA, Plant
- DNA, Protozoan
- DNA, Recombinant
- DNA, Ribosomal
- DNA, Satellite
- DNA, Single-Stranded
- DNA, Viral
- DNA, Z-Form
- Isochores
- Retroelements
This graph shows the total number of publications written about "DNA" by people in this website by year, and whether "DNA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 19 | 32 | 51 |
1995 | 12 | 33 | 45 |
1996 | 22 | 28 | 50 |
1997 | 11 | 32 | 43 |
1998 | 16 | 35 | 51 |
1999 | 14 | 31 | 45 |
2000 | 22 | 57 | 79 |
2001 | 12 | 52 | 64 |
2002 | 31 | 43 | 74 |
2003 | 24 | 52 | 76 |
2004 | 20 | 77 | 97 |
2005 | 16 | 54 | 70 |
2006 | 20 | 40 | 60 |
2007 | 24 | 27 | 51 |
2008 | 17 | 22 | 39 |
2009 | 26 | 20 | 46 |
2010 | 22 | 26 | 48 |
2011 | 19 | 31 | 50 |
2012 | 28 | 20 | 48 |
2013 | 24 | 19 | 43 |
2014 | 24 | 17 | 41 |
2015 | 19 | 24 | 43 |
2016 | 17 | 10 | 27 |
2017 | 30 | 11 | 41 |
2018 | 9 | 15 | 24 |
2019 | 16 | 8 | 24 |
2020 | 14 | 15 | 29 |
2021 | 12 | 16 | 28 |
2022 | 6 | 42 | 48 |
2023 | 4 | 50 | 54 |
2024 | 3 | 11 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA" by people in Profiles.
-
Updated understanding of the protein-DNA recognition code used by C2H2 zinc finger proteins. Curr Opin Struct Biol. 2024 Aug; 87:102836.
-
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2322934121.
-
Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages. PLoS One. 2024; 19(4):e0301904.
-
Structural basis of DNA crossover capture by Escherichia coli DNA gyrase. Science. 2024 04 12; 384(6692):227-232.
-
GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer. Nat Commun. 2024 Mar 08; 15(1):2132.
-
One form and two functions: MBD of SETDB2 is a protein-interacting domain. Structure. 2024 Mar 07; 32(3):258-260.
-
MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis. J Exp Clin Cancer Res. 2024 Mar 05; 43(1):68.
-
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. J Infect Dis. 2024 Feb 14; 229(2):413-421.
-
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Ka Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discov. 2024 Feb 08; 14(2):240-257.
-
Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF. Nucleic Acids Res. 2024 Jan 11; 52(1):4-21.